INDV — Indivior Pharmaceuticals, Inc.
Exchange: NASDAQ • IR Tier: D
Subscribe to INDV Earnings Calendar
http://earningstracker.com/cal/INDV.ics
Add to Google Calendar
Sentiment Analysis
| Analyzer | Overall | Avg Score | Avg Confidence | Positive | Neutral | Negative | Reports |
|---|---|---|---|---|---|---|---|
| finbert-finbert | neutral | 0.23 | 91% | 4 | 6 | 1 | 11 |
| vader | positive | 0.55 | 37% | 6 | 5 | 0 | 11 |
Earnings History
| Period | Date | Timing | Status | Call Time (ET) | EPS | Revenue | Sentiment |
|---|---|---|---|---|---|---|---|
| Q3 2025 | 2025-10-30 | BMO | CONFIRMED | 08:00 EDT | — | $314 million | POSITIVE |
| Q2 2025 | 2025-07-31 | BMO | CONFIRMED | 08:00 EDT | — | $302 million | POSITIVE |
| Q1 2025 | 2025-04-24 | — | CONFIRMED | — | — | $266 million | POSITIVE |
| Q4 2024 | 2025-02-20 | — | CONFIRMED | — | — | $1188 million | NEUTRAL |
| Q4 2025 | 2025-02-04 | BMO | CONFIRMED | — | — | $252 million | POSITIVE |
Insider Activity last 180 days · open-market only
| Date | Insider | Role | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| 2026-08-27 | Anderson Woodrow D | Chief Accounting Officer | 1,500 | $35.69 | +$54K |